Current status of theranostics in prostate cancer
Crossref DOI link: https://doi.org/10.1007/s00259-017-3882-2
Published Online: 2017-12-28
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Virgolini, Irene
Decristoforo, Clemens
Haug, Alexander
Fanti, Stefano
Uprimny, Christian
Funding for this research was provided by:
University of Innsbruck and Medical University of Innsbruck
License valid from 2017-12-28